Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01248247 |
| Title | BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | M.D. Anderson Cancer Center|AstraZeneca|Bayer|Merck Sharp & Dohme Corp.|National Cancer Institute (NCI)|OSI Pharmaceutic |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |